Clinical Trials Industry in India: A Systematic Review

This study shows that many global clinical trials organisations have relocated their clinical trial (CT) research units to India. The Indian CT industry has become one of the most cost-efficient destinations in the world. It is growing fast and has emerged as a popular destination for global clinical trials. However, the process followed by the pharmaceutical companies for conducting CTs has raised some critical issues. The authors of this paper argue that the Government of India needs to establish a policy framework for the Indian CT industry to provide for easy access to affordable drugs developed through adaptive clinical trials and create a regulatory environment capable of ensuring the conduct of clinical trials without violation of humanitarian ethics and other social norms.